Return to:
Asthma ArticlesOr:
Recent Asthma Articleshttp://www.cnbc.com/id/21381058/for/cnbcCNBC - NEW YORK - Shares of AstraZeneca PLC fell Friday, after the British drug maker lost a European patent for asthma treatment Symbicort. AstraZeneca said Thursday the European Patent Office appeals board revoked the European combination patent for ...
Article Finder:
October 19, 2007 11:43:00 AM